具有抗炎活性的新型类固醇来自Physalis minima的整个植物
Jiangping Wu1,2,3, Qiuyue Lv1,2, Jie Yu1,2
1Anhui Provincial Engineering Laboratory for Screening and Re-evaluation of Active Compounds of Herbal Medicines in Southern Anhui, Wannan Medical College, Wuhu, China.
研究人员从*Physalis minima*中分离出了两种新的类固醇,并测试了它们的抗炎作用. 化合物1-3显示免疫细胞中氧化产生的中度抑制.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- *Physalis minima*是一种因其多样化的植物化学成分而闻名的植物物种.
- 类固醇是一种具有显著生物活性的有机化合物.
- 炎症是一种复杂的生物反应,与各种疾病有关.
研究的目的:
- 从*Physalis minima**中分离和描述新的类固醇化合物.
- 评估隔离化合物的抗炎潜力.
- 确定新型类固醇的结构和绝对配置.
主要方法:
- 使用色谱技术分离化合物.
- 通过综合光谱分析 (NMR,MS) 阐明结构.
- 使用计算式电子循环二元化 (ECD) 计算来确定绝对配置.
- 在体外抗炎测定测量氧化 (NO) 抑制在LPS刺激的RAW 264.7细胞.
主要成果:
- 确定了两种新的类固醇,即phyminiolide J (1) 和phyministerol A (2).
- 三种已知的化合物 (3-5) 也被分离和描述.
- 化合物1-3通过抑制氧化的产生表现出中度的抗炎活性.
- 化合物1-3的IC50值在9.73至23.26μM之间.
结论:
- 菲米尼奥利德J和菲米尼斯特醇A是来自*Physalis minima*的新型类固醇化合物.
- 孤立的类固醇,特别是1-3类固醇,具有显著的抗炎性质.
- 这些发现表明Physalis minima作为抗炎药物的潜在来源.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
相关概念视频
Plant Hormones
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Cell Signaling in Plants
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
